Vitamin C for the Prevention of UTI in Women Who Undergo Elective GYN Surgeries

Overview

This open-label randomized trial aims at assessing the role of Vitamin C pills in the prevention of catheter-associated urinary tract infections in women undergoing elective gynecological surgeries.

Full Title of Study: “Vitamin C for the Prevention of UTI in Women Who Undergo Elective GYN Surgeries: a Study Protocol for a Randomized Controlled Trial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: None (Open Label)
  • Study Primary Completion Date: July 12, 2019

Interventions

  • Drug: Ascorbic Acid 1000 MG
    • 1000 mg ascorbic acid (Vitamin C) for 1 month post-op after an elective gynecological surgery.

Arms, Groups and Cohorts

  • Experimental: Women on a vitamin C regimen
    • Women who are undergoing elective gynecological surgeries and who are randomized to take 1000 mg of vitamin C for one month,
  • No Intervention: Women not taking vitamin C
    • Women who are undergoing elective gynecological surgeries and who are randomized not to take any vitamin C for one month.

Clinical Trial Outcome Measures

Primary Measures

  • Proportion of participants who experienced clinically diagnosed and treated UTI.
    • Time Frame: 30 days
    • Urinary tract infection is diagnosed by a positive urine culture.

Participating in This Clinical Trial

Inclusion Criteria

Non pregnant women at least 18 years of age visiting the Preadmission unit (PAU) or the OBGYN floor (7N), presenting for elective GYN surgery at the American University of Beirut Medical Center (AUBMC). Exclusion Criteria:

  • Any women with the following: 1. Nephrolithiasis 2. Congenital anomaly or neurogenic bladder 3. Allergy to ascorbic acid 4. Who require therapeutic anticoagulant medicine during the 6 weeks after surgery 5. Surgery did involve a fistula repair or a vaginal mesh removal 6. Positive Urinalysis in the PAU 7. Recurrent UTI's 8. Diabetes 9. G6PD 10. Hemochromatosis 11. Renal disorders Patients already taking Vitamin C supplementation will also be excluded from the study.

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • American University of Beirut Medical Center
  • Provider of Information About this Clinical Study
    • Principal Investigator: Tony Bazi, MD – American University of Beirut Medical Center
  • Overall Official(s)
    • Tony Bazi, MD, Principal Investigator, American University of Beirut Medical Center

Citations Reporting on Results

Foxman B, Cronenwett AE, Spino C, Berger MB, Morgan DM. Cranberry juice capsules and urinary tract infection after surgery: results of a randomized trial. Am J Obstet Gynecol. 2015 Aug;213(2):194.e1-8. doi: 10.1016/j.ajog.2015.04.003. Epub 2015 Apr 13.

Ochoa-Brust GJ, Fernandez AR, Villanueva-Ruiz GJ, Velasco R, Trujillo-Hernandez B, Vasquez C. Daily intake of 100 mg ascorbic acid as urinary tract infection prophylactic agent during pregnancy. Acta Obstet Gynecol Scand. 2007;86(7):783-7. doi: 10.1080/00016340701273189.

Carlsson S, Wiklund NP, Engstrand L, Weitzberg E, Lundberg JO. Effects of pH, nitrite, and ascorbic acid on nonenzymatic nitric oxide generation and bacterial growth in urine. Nitric Oxide. 2001 Dec;5(6):580-6. doi: 10.1006/niox.2001.0371.

Trautner BW, Darouiche RO. Catheter-associated infections: pathogenesis affects prevention. Arch Intern Med. 2004 Apr 26;164(8):842-50. doi: 10.1001/archinte.164.8.842.

Barbosa-Cesnik C, Brown MB, Buxton M, Zhang L, DeBusscher J, Foxman B. Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial. Clin Infect Dis. 2011 Jan 1;52(1):23-30. doi: 10.1093/cid/ciq073.

Hickling DR, Nitti VW. Management of recurrent urinary tract infections in healthy adult women. Rev Urol. 2013;15(2):41-8.

Wald HL, Ma A, Bratzler DW, Kramer AM. Indwelling urinary catheter use in the postoperative period: analysis of the national surgical infection prevention project data. Arch Surg. 2008 Jun;143(6):551-7. doi: 10.1001/archsurg.143.6.551.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.